CN117598950B - 一种含卡瓦胡椒根的提取物、制备方法和在舒缓修护功效化妆品中的应用 - Google Patents
一种含卡瓦胡椒根的提取物、制备方法和在舒缓修护功效化妆品中的应用 Download PDFInfo
- Publication number
- CN117598950B CN117598950B CN202311642989.1A CN202311642989A CN117598950B CN 117598950 B CN117598950 B CN 117598950B CN 202311642989 A CN202311642989 A CN 202311642989A CN 117598950 B CN117598950 B CN 117598950B
- Authority
- CN
- China
- Prior art keywords
- kava
- fermentation
- extract
- mung bean
- pichia pastoris
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000284 extract Substances 0.000 title claims abstract description 103
- 230000000694 effects Effects 0.000 title claims abstract description 72
- 229940107491 kava root Drugs 0.000 title claims abstract description 60
- 238000002360 preparation method Methods 0.000 title claims abstract description 51
- 239000002537 cosmetic Substances 0.000 title claims abstract description 14
- 238000000855 fermentation Methods 0.000 claims abstract description 132
- 230000004151 fermentation Effects 0.000 claims abstract description 131
- 240000004922 Vigna radiata Species 0.000 claims abstract description 85
- 235000010721 Vigna radiata var radiata Nutrition 0.000 claims abstract description 85
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 claims abstract description 85
- 240000005546 Piper methysticum Species 0.000 claims abstract description 58
- 235000016787 Piper methysticum Nutrition 0.000 claims abstract description 57
- 239000000758 substrate Substances 0.000 claims abstract description 51
- 241000235058 Komagataella pastoris Species 0.000 claims abstract description 49
- 238000001914 filtration Methods 0.000 claims abstract description 12
- 230000001954 sterilising effect Effects 0.000 claims abstract description 11
- 238000005336 cracking Methods 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 33
- 239000001963 growth medium Substances 0.000 claims description 22
- 235000015097 nutrients Nutrition 0.000 claims description 18
- 239000000725 suspension Substances 0.000 claims description 18
- 239000002609 medium Substances 0.000 claims description 17
- 238000000265 homogenisation Methods 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 11
- 241001477352 Bengalia Species 0.000 claims description 7
- 235000019733 Fish meal Nutrition 0.000 claims description 7
- 240000008042 Zea mays Species 0.000 claims description 7
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 7
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 7
- 235000013339 cereals Nutrition 0.000 claims description 7
- 235000005822 corn Nutrition 0.000 claims description 7
- 239000004467 fishmeal Substances 0.000 claims description 7
- 239000007222 ypd medium Substances 0.000 claims description 6
- 238000009630 liquid culture Methods 0.000 claims description 5
- 238000011081 inoculation Methods 0.000 claims description 2
- 238000004659 sterilization and disinfection Methods 0.000 claims description 2
- 231100000344 non-irritating Toxicity 0.000 abstract description 2
- 230000000052 comparative effect Effects 0.000 description 93
- 239000000843 powder Substances 0.000 description 58
- 238000012360 testing method Methods 0.000 description 52
- 239000000243 solution Substances 0.000 description 17
- 150000003278 haem Chemical class 0.000 description 14
- 208000002193 Pain Diseases 0.000 description 12
- 230000001914 calming effect Effects 0.000 description 12
- 238000012258 culturing Methods 0.000 description 12
- 239000002054 inoculum Substances 0.000 description 11
- 230000008859 change Effects 0.000 description 10
- 210000000582 semen Anatomy 0.000 description 10
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 9
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 9
- 239000008367 deionised water Substances 0.000 description 9
- 229910021641 deionized water Inorganic materials 0.000 description 9
- 238000000605 extraction Methods 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 9
- 240000006439 Aspergillus oryzae Species 0.000 description 8
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 8
- 241000186673 Lactobacillus delbrueckii Species 0.000 description 7
- 239000011159 matrix material Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000013543 active substance Substances 0.000 description 6
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 6
- 244000068988 Glycine max Species 0.000 description 5
- 235000010469 Glycine max Nutrition 0.000 description 5
- 239000012141 concentrate Substances 0.000 description 5
- 230000001815 facial effect Effects 0.000 description 5
- 230000000638 stimulation Effects 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 240000001417 Vigna umbellata Species 0.000 description 4
- 235000011453 Vigna umbellata Nutrition 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 230000008020 evaporation Effects 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 238000011056 performance test Methods 0.000 description 4
- 230000008439 repair process Effects 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 230000008591 skin barrier function Effects 0.000 description 4
- 239000004458 spent grain Substances 0.000 description 4
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 229960002504 capsaicin Drugs 0.000 description 3
- 235000017663 capsaicin Nutrition 0.000 description 3
- 230000035784 germination Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- 241000186840 Lactobacillus fermentum Species 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 2
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 235000013405 beer Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 2
- 229960001631 carbomer Drugs 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 229940012969 lactobacillus fermentum Drugs 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000001603 reducing effect Effects 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000007873 sieving Methods 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 229960004418 trolamine Drugs 0.000 description 2
- 238000002137 ultrasound extraction Methods 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 206010064503 Excessive skin Diseases 0.000 description 1
- XEAQIWGXBXCYFX-GUOLPTJISA-N Kawain Chemical compound C1C(OC)=CC(=O)O[C@H]1\C=C\C1=CC=CC=C1 XEAQIWGXBXCYFX-GUOLPTJISA-N 0.000 description 1
- 241000272041 Naja Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000758706 Piperaceae Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940124623 antihistamine drug Drugs 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- YXVFQADLFFNVDS-UHFFFAOYSA-N diammonium citrate Chemical compound [NH4+].[NH4+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O YXVFQADLFFNVDS-UHFFFAOYSA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- XEAQIWGXBXCYFX-UHFFFAOYSA-N dl-kavain Natural products C1C(OC)=CC(=O)OC1C=CC1=CC=CC=C1 XEAQIWGXBXCYFX-UHFFFAOYSA-N 0.000 description 1
- 244000013123 dwarf bean Species 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- -1 flavonoid compounds Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 150000002333 glycines Chemical class 0.000 description 1
- 235000021331 green beans Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 150000002559 kavalactones Chemical class 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000006872 mrs medium Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 230000037070 skin defense Effects 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Birds (AREA)
- Cosmetics (AREA)
Abstract
Description
测试样品 | 皮肤血红素值变化率(%) |
空白对照 | -8.6 |
实施例1 | -35.2 |
实施例2 | -35.0 |
实施例3 | -27.3 |
实施例4 | -32.5 |
实施例5 | -33.8 |
实施例6 | -32.0 |
实施例7 | -29.7 |
实施例8 | -28.5 |
实施例9 | -34.8 |
实施例10 | -31.1 |
对比例1 | -15.4 |
对比例2 | -10.5 |
对比例3 | -12.3 |
对比例4 | -21.8 |
对比例5 | -14.2 |
对比例6 | -25.2 |
对比例7 | -16.9 |
对比例8 | -20.6 |
对比例9 | -18.3 |
对比例10 | -22.1 |
对比例11 | -20.8 |
对比例12 | -15.4 |
对比例13 | -21.0 |
对比例14 | -13.6 |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311642989.1A CN117598950B (zh) | 2023-12-01 | 2023-12-01 | 一种含卡瓦胡椒根的提取物、制备方法和在舒缓修护功效化妆品中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311642989.1A CN117598950B (zh) | 2023-12-01 | 2023-12-01 | 一种含卡瓦胡椒根的提取物、制备方法和在舒缓修护功效化妆品中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN117598950A CN117598950A (zh) | 2024-02-27 |
CN117598950B true CN117598950B (zh) | 2024-05-14 |
Family
ID=89945993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311642989.1A Active CN117598950B (zh) | 2023-12-01 | 2023-12-01 | 一种含卡瓦胡椒根的提取物、制备方法和在舒缓修护功效化妆品中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117598950B (zh) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005000161A (ja) * | 2003-01-28 | 2005-01-06 | Morinaga & Co Ltd | トウガラシ又はカプシノイド含有植物の発酵組成物 |
CN113143812A (zh) * | 2020-12-31 | 2021-07-23 | 江苏瑞霆生物科技有限公司 | 一种卡瓦胡椒发酵物的制备方法和产品及其在化妆品中的应用 |
CN115006314A (zh) * | 2022-07-11 | 2022-09-06 | 科乐美(广州)生物科技有限公司 | 一种卡瓦胡椒提取物及其制备方法和应用 |
CN115074393A (zh) * | 2022-08-04 | 2022-09-20 | 江苏创健医疗科技有限公司 | 一种巴斯德毕赤酵母发酵溶胞物滤液、制备方法及应用 |
CN115105449A (zh) * | 2022-07-19 | 2022-09-27 | 广州陶妆生物科技有限公司 | 一种新型抗菌消炎祛痘霜及其制备方法 |
CN115227607A (zh) * | 2022-08-01 | 2022-10-25 | 广州丽彦妆生物科技有限公司 | 一种甘草修护组合物、甘草修护冻干面膜及其制备方法 |
-
2023
- 2023-12-01 CN CN202311642989.1A patent/CN117598950B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005000161A (ja) * | 2003-01-28 | 2005-01-06 | Morinaga & Co Ltd | トウガラシ又はカプシノイド含有植物の発酵組成物 |
CN113143812A (zh) * | 2020-12-31 | 2021-07-23 | 江苏瑞霆生物科技有限公司 | 一种卡瓦胡椒发酵物的制备方法和产品及其在化妆品中的应用 |
CN115006314A (zh) * | 2022-07-11 | 2022-09-06 | 科乐美(广州)生物科技有限公司 | 一种卡瓦胡椒提取物及其制备方法和应用 |
CN115105449A (zh) * | 2022-07-19 | 2022-09-27 | 广州陶妆生物科技有限公司 | 一种新型抗菌消炎祛痘霜及其制备方法 |
CN115227607A (zh) * | 2022-08-01 | 2022-10-25 | 广州丽彦妆生物科技有限公司 | 一种甘草修护组合物、甘草修护冻干面膜及其制备方法 |
CN115074393A (zh) * | 2022-08-04 | 2022-09-20 | 江苏创健医疗科技有限公司 | 一种巴斯德毕赤酵母发酵溶胞物滤液、制备方法及应用 |
Also Published As
Publication number | Publication date |
---|---|
CN117598950A (zh) | 2024-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106562162A (zh) | 一种海棠果益生菌发酵饮品及其制备方法 | |
CN110591881B (zh) | 一种富含Monacolin K和γ-氨基丁酸的枸杞醋及其制备方法 | |
CN113143812B (zh) | 一种卡瓦胡椒发酵物的制备方法和产品及其在化妆品中的应用 | |
CN105969636A (zh) | 一种糙米红曲醋的制备方法 | |
CN115678805B (zh) | 一种具有修复抗衰功效的松茸酵母发酵液的制备方法及其应用 | |
CN107254384B (zh) | 一种甜酒药的制备方法 | |
CN110477239A (zh) | 一种具养颜美容的草本萃取发酵果蔬液的制备方法 | |
CN101396111B (zh) | 一种酱油复合发酵液、其制备方法及用途 | |
CN108977306A (zh) | 一种保健型白酒的生产方法 | |
CN112877173A (zh) | 一种黑茶复合茯苓液态发酵菌丝保健醋及其制备方法 | |
CN117598950B (zh) | 一种含卡瓦胡椒根的提取物、制备方法和在舒缓修护功效化妆品中的应用 | |
CN107460072A (zh) | 一种无酒味甜酒酿所用开胃型甜酒曲及其制备方法 | |
CN116459203A (zh) | 一种双歧杆菌/糙米发酵产物溶胞物的制备方法及其应用 | |
CN106318788A (zh) | 一种富硒紫薯发酵酒的酿造方法 | |
CN109673792A (zh) | 苦荞发酵茶的制备方法 | |
CN108624443A (zh) | 一种富含花青苷的低酒度黄酒及其生产方法 | |
CN105441278B (zh) | 一种胡颓子果实深加工的方法 | |
CN113648254A (zh) | 可用于化妆品的羽扇豆针叶樱桃发酵物及其制备方法 | |
CN112574850A (zh) | 一种药曲老陈醋及其酿造方法 | |
CN111733038A (zh) | 一种肉苁蓉保健酒及其制备方法 | |
CN105567503A (zh) | 一种具有辅助降血糖功能的莜麦酒的制备方法 | |
CN104673610B (zh) | 一种松露苦荞保健酒及其制备方法 | |
CN110801015A (zh) | 健脑安神和增强记忆作用的核桃紫苏鱼油胶囊及制备方法 | |
CN117904247B (zh) | 一种具有紧致修护功效的乳酸杆菌豆浆发酵产物及其制备方法和应用 | |
CN104694352A (zh) | 一种石斛苦荞保健酒及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20240510 Address after: Room 405, No. 263 Gaotang Road, Tianhe District, Guangzhou City, Guangdong Province, 510000 (office only) Applicant after: Guangzhou Convergence Biotechnology Co.,Ltd. Country or region after: China Address before: Room 307, Building 4, No. 19 Mupi East Road, Tianhe District, Guangzhou City, Guangdong Province, 510000 Applicant before: Guangzhou Xinghui Biotechnology Co.,Ltd. Country or region before: China |
|
TA01 | Transfer of patent application right |